Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B H Devens

Showing results (1-10 of 21) with videos related to

Pageof 3
Sort By:
Cellular Immunology|March 1, 1995
Phenotypic identification of specific and nonspecific suppressor T-cell populations involved in the in vivo response to alloantigenB H Devens, D R Webb
Immunopharmacology|December 1, 1985
Investigations into the mechanism of immunosuppression caused by acute treatment with O,O,S-trimethyl phosphorothioate. II. Effect on the ability of murine macrophages to present antigenK E Rodgers, T Imamura, B H Devens
Immunopharmacology|December 1, 1986
Organophosphorus pesticide immunotoxicity: effects of O,O,S-trimethyl phosphorothioate on cellular and humoral immune response systemsK E Rodgers, T Imamura, B H Devens
Journal of Immunology (Baltimore, Md. : 1950)|November 1, 1988
Antipeptide antibody specific for the N-terminal of soluble immune response suppressor neutralizes concanavalin A and IFN-induced suppressor cell activity in an in vitro cytotoxic T lymphocyte responseB H Devens, G Semenuk, D R Webb
Toxicology and Applied Pharmacology|April 1, 1987
Investigations into the mechanism of immunosuppression caused by acute treatment with O,O,S-trimethyl phosphorothioate: generation of suppressive macrophages from treated animalsK E Rodgers, T Imamura, B H Devens
Immunopharmacology|December 1, 1985
Investigations into the mechanism of immunosuppression caused by acute treatment with O,O,S-trimethyl phosphorothioate. I. Characterization of the immune cell population affectedK E Rodgers, T Imamura, B H Devens
Chemical Immunology|January 1, 1994
Suppressor cells and immunityD R Webb, E Kraig, B H Devens
Toxicology and Applied Pharmacology|November 1, 1985
Effects of subchronic treatment with O,O,S-trimethyl phosphorothioate on cellular and humoral immune response systemsK E Rodgers, T Imamura, B H Devens
Journal of Immunology (Baltimore, Md. : 1950)|April 1, 1984
Production of human-human hybridomas secreting antibody to sheep erythrocytes after in vitro immunizationL E Strike, B H Devens, R L Lundak
Cancer Letters|January 1, 1984
Induction of murine fibrosarcomas by low dose treatment with 3-methylcholanthrene followed by promotion with 12-O-tetradecanoyl-phorbol-13-acetateB H Devens, R L Lundak, C V Byus
Pageof 3

Showing results (1-10 of 21) with videos related to

Sort By:
Pageof 3
Cellular Immunology|March 1, 1995
Phenotypic identification of specific and nonspecific suppressor T-cell populations involved in the in vivo response to alloantigenB H Devens, D R Webb
Immunopharmacology|December 1, 1985
Investigations into the mechanism of immunosuppression caused by acute treatment with O,O,S-trimethyl phosphorothioate. II. Effect on the ability of murine macrophages to present antigenK E Rodgers, T Imamura, B H Devens
Immunopharmacology|December 1, 1986
Organophosphorus pesticide immunotoxicity: effects of O,O,S-trimethyl phosphorothioate on cellular and humoral immune response systemsK E Rodgers, T Imamura, B H Devens
Journal of Immunology (Baltimore, Md. : 1950)|November 1, 1988
Antipeptide antibody specific for the N-terminal of soluble immune response suppressor neutralizes concanavalin A and IFN-induced suppressor cell activity in an in vitro cytotoxic T lymphocyte responseB H Devens, G Semenuk, D R Webb
Toxicology and Applied Pharmacology|April 1, 1987
Investigations into the mechanism of immunosuppression caused by acute treatment with O,O,S-trimethyl phosphorothioate: generation of suppressive macrophages from treated animalsK E Rodgers, T Imamura, B H Devens
Immunopharmacology|December 1, 1985
Investigations into the mechanism of immunosuppression caused by acute treatment with O,O,S-trimethyl phosphorothioate. I. Characterization of the immune cell population affectedK E Rodgers, T Imamura, B H Devens
Chemical Immunology|January 1, 1994
Suppressor cells and immunityD R Webb, E Kraig, B H Devens
Toxicology and Applied Pharmacology|November 1, 1985
Effects of subchronic treatment with O,O,S-trimethyl phosphorothioate on cellular and humoral immune response systemsK E Rodgers, T Imamura, B H Devens
Journal of Immunology (Baltimore, Md. : 1950)|April 1, 1984
Production of human-human hybridomas secreting antibody to sheep erythrocytes after in vitro immunizationL E Strike, B H Devens, R L Lundak
Cancer Letters|January 1, 1984
Induction of murine fibrosarcomas by low dose treatment with 3-methylcholanthrene followed by promotion with 12-O-tetradecanoyl-phorbol-13-acetateB H Devens, R L Lundak, C V Byus
Pageof 3